Weekly Wrap Up National Infant Immunization Week, April 22 – 29
National Infant Immunization Week (NIIW) is a yearly observance held in April, highlighting the importance of protecting children two years and younger from vaccine-preventable diseases (VPDs). NIIW is April 22 – 29, 2024. Find tips for talking with parents, key messages, and other resources on the CDC NIIW page.
Return to Table of Contents JYNNEOS Commercialization
Mpox vaccine JYNNEOS became available on the commercial market as of April 1, 2024. There are no changes to the current ordering process. To ensure continued supplies through the summer and upcoming LGBTQ+ PRIDE season, CDPH recommends: - LHDs and providers use their previous years doses administered as a base to estimate how much vaccine is needed to continue to vaccinate through PRIDE season.
- Order doses you think you will need by Thursday, April 25, 2024.
JYNNEOS is covered by Medi-Cal without prior authorization, and it will be published on the Medi-Cal contracted drug list in June.
For commercial availability, refer to this list of product distributors.
Return to Table of Contents PEMGARDA (pemivibart) Emergency Use Authorization (EUA) Updates
PEMGARDA (pemivibart) is a recombinant monoclonal antibody that has not been approved, but has been authorized by the Food and Drug Administration (FDA) under an EUA for the pre-exposure prophylaxis (PrEP) of COVID-19 in certain adults and adolescent individuals (12 years of age and older weighing at least 40 kg): - Who are not currently infected with SARS-CoV-2 and who have not had a known recent exposure to an individual infected with SARS CoV-2 and
- Who have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments and are unlikely to mount an adequate response to COVID-19 vaccination.
Here is what providers need to know: - Initial dose: 4500 mg administered as a single IV infusion over a minimum of 60 minutes.
- Repeat dose: As above. Repeat dosing can be given every 3 months.
- Contraindicated in individuals with previous severe hypersensitivity reactions (anaphylaxis) to any component of PEMGARDA.
- For individuals with a severe hypersensitivity reaction to a COVID-19 vaccine, consult with an allergist/immunologist.
- Please track all serious adverse events and medication errors:
For more information refer to the following resources: Return to Table of Contents Vaccines for Adults (VFA) Ordering Now Open
Quarter two VFA ordering takes place April 15 – 30, 2024. To access ordering, VFA sites must have already completed VFA recertification on myCAvax. If your clinic location has NOT yet completed this process, take steps as soon as possible!
For more information please see the VFA Ordering Letter.
Return to Table of Contents Excursion Report File size and Type Guidelines
Do you have a temperature excursion to report in myCAvax? If so, keep in mind that providers must submit temperature data from the past 90 days while reporting Excursion events.
The accepted file types are .pdf, .png, and .jpg and the file must be less than 3MB in size. - Uploading a file that is too large or in an incorrect format will result in an error.
- In case you are unable to submit the Excursion report due to the larger file size, upload a reduced file under 3MB to submit the report and upload the larger file(s) post-submission.
Contact the Provider Call Center at (833) 502-1245, or providercallcenter@cdph.ca.gov (Monday – Friday, 8:00am – 5:00pm, PT) if you require assistance with uploading the files or have questions about the process. Note that the Provider Call Center will not be able to clean up any junk data or delete incorrect submissions.
Return to Table of Contents Upcoming Webinars and Training Vaccines for Adults (VFA) Office Hours: get your questions answered about the VFA program in myCAvax - Register for Tuesday, April 23, 2024, 2:00pm – 2:30pm (PT)
CDPH Immunization Branch Updates for Providers Webinar (occurs every other Friday) June 2024 California Immunization Coalition Summit Return to Table of Contents Support Opportunities
Provider Call Center For Program information: email providercallcenter@cdph.ca.gov or call (833) 502-1245 (Monday - Friday, 8:00am - 5:00pm, PT) myCAvax Help Desk For technical issues (e.g., password resets): email myCAvax.HD@cdph.ca.gov or call (833) 502-1245, (Monday – Friday, 8:00am – 5:00pm, PT) System related training materials are available via the Knowledge Center in myCAvax and at EZIZ.org. My Turn Help Desk Return to Table of Contents |
